4
Changes in Ownership
SUTRO BIOPHARMA, INC. Filed Acc 0001872398-25-000005
Chief Executive Officer gave up 894 shares (to pay taxes)
- Chief Executive Officer acquired 2,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chung Jane Chief Executive Officer | 2025-12-12 | Option exercise | +2,500 | 14,785 | D | ||
| Chung Jane Chief Executive Officer | 2025-12-12 | Shares withheld for taxes | −894 | $8.02 | $7,165 | 13,891 | D |
| Derivatives | |||||||
| Chung Jane Chief Executive Officer | 2025-12-12 | Option exercise · Restricted Stock Unit (RSU) | −2,500 | 5,000 | D | ||
Loading xslF345X05/form4-12172025_011222.xml…